Skip to main content

CVS Health Corp.

  • Generic utilization lifts CVS Health in Q3

    Tailwinds from specialty pharmacy and increased generic utilization lifted CVS Health up on Tuesday, as the company posted net revenues of $35 billion, representing an increase of 9.7% for the three months ended Sept. 30.

  • CVS Q3 revenue up 10%

    Woonsocket, R.I. -- CVS Health Corp. on Tuesday reported slightly higher-than-expected quarterly profit, helped in part by growth in sales of specialty drugs. Net income decreased 24% to $900 million from $1.21 billion in the year-ago period, primarily due to a $521 million pre-tax loss on the early extinguishment of debt.      
  • CVS/pharmacy awarded LEED Platinum for store in New Haven, Conn.

    Woonsocket, R.I. -- CVS Health said that the CVS/pharmacy store in West Haven, Conn., has been awarded LEED (Leadership in Energy and Environmental Design) Platinum certification. It the first CVS store to be certified with the U.S. Green Building Council’s highest distinction and the retailer’s eighth LEED-certified building.
   
  • CVS pushes for ‘tobacco-free pharmacy network’

    CVS Health has confirmed a Wall Street Journal report that it is working to establish a tobacco-free pharmacy network and is looking for tobacco-free pharmacies to participate in the new offering.

    As widely reported, CVS Health’s pharmacy locations are now officially tobacco-free as the company forges ahead on its mission to help shape the future of health care.

  • CVS Health CEO Larry Merlo discusses leadership in healthcare innovation

    With the recent unveiling of a new corporate name and a network of retail pharmacies that are now officially tobacco-free, CVS Health continues to forge ahead on its mission to help shape the future of health care. To further communicate its purpose to both consumers and press and to discuss how the company’s unique, integrated model is making a difference in healthcare, Larry Merlo, president and CEO of CVS Health, spoke on Friday before the National Press Club in Washington, D.C.

  • CVS names legal expert as strategy VP

    Woonsocket, R.I. - Mary Langowski has been named executive VP for strategy, policy and market development for CVS Health, effective Oct. 14. In this role, Langowski will direct CVS Health's strategy and market development functions, with a focus on identifying and expanding enterprise opportunities to new markets.

    Her portfolio will also include leading the company's government affairs and policy development teams at the state and federal level, providing strategic counsel.

  • CVS appoints EVP for strategy, policy and market development

    CVS Health has named Mary Langowski EVP for strategy, policy and market development, effective Oct. 14.

    Langowski will join CVS Health from international law firm DLA Piper where she serves as the chair of the Health Care Policy and Regulatory Practice and the co-chair of the Food and Beverage Sector.

  • CVS closes Navarro Discount Pharmacy acquisition

    CVS Health has completed the purchase of Miami-based Navarro Discount Pharmacy.

    The acquisition includes Navarro's 33 retail locations and Navarro Health Services, a specialty pharmacy serving patients with complex or chronic diseases. The retail pharmacies will retain the Navarro Discount Pharmacy name.

X
This ad will auto-close in 10 seconds